Philadelphia Trust Company’s Xylem XYL Stock Holding History

Philadelphia Trust Company’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$404K	Buy	3,377 +71	+2%	+$9.31K	0.03%	182
2025 Q4	$450K	Buy	3,306 +84	+3%	+$12.1K	0.03%	168
2025 Q3	$475K	Hold	3,222	–	–	0.03%	160
2025 Q2	$417K	Sell	3,222 -20	-0.6%	-$2.42K	0.03%	165
2025 Q1	$387K	Hold	3,242	–	–	0.03%	174
2024 Q4	$376K	Hold	3,242	–	–	0.03%	176
2024 Q3	$438K	Hold	3,242	–	–	0.03%	165
2024 Q2	$440K	Sell	3,242 -503	-13%	-$68.4K	0.03%	154
2024 Q1	$484K	Buy	3,745 +715	+24%	+$86.4K	0.04%	157
2023 Q4	$347K	Sell	3,030 -200	-6%	-$20K	0.03%	171
2023 Q3	$294K	Hold	3,230	–	–	0.03%	181
2023 Q2	$364K	Hold	3,230	–	–	0.03%	173
2023 Q1	$338K	Hold	3,230	–	–	0.03%	179
2022 Q4	$357K	Hold	3,230	–	–	0.04%	177
2022 Q3	$282K	Buy	3,230 +273	+9%	+$24.8K	0.03%	182
2022 Q2	$231K	Sell	2,957 -1,730	-37%	-$143K	0.02%	191
2022 Q1	$400K	Sell	4,687 -125	-3%	-$12K	0.03%	180
2021 Q4	$577K	Hold	4,812	–	–	0.04%	160
2021 Q3	$595K	Buy	4,812 +65	+1%	+$8.37K	0.04%	160
2021 Q2	$569K	Hold	4,747	–	–	0.04%	170
2021 Q1	$499K	Buy	4,747 +10	+0.2%	+$1.01K	0.04%	169
2020 Q4	$482K	Buy	4,737 +1,415	+43%	+$133K	0.04%	156
2020 Q3	$279K	Buy	+3,322	New	+$259K	0.03%	179
2020 Q1	–	Sell	-3,422	Closed	-$270K	–	199
2019 Q4	$270K	Hold	3,422	–	–	0.02%	181
2019 Q3	$272K	Hold	3,422	–	–	0.03%	185
2019 Q2	$286K	Sell	3,422 -66	-2%	-$5.26K	0.03%	190
2019 Q1	$276K	Sell	3,488 -2,210	-39%	-$161K	0.02%	185
2018 Q4	$380K	Sell	5,698 -325	-5%	-$22.5K	0.04%	142
2018 Q3	$481K	Hold	6,023	–	–	0.04%	152
2018 Q2	$406K	Hold	6,023	–	–	0.04%	160
2018 Q1	$463K	Hold	6,023	–	–	0.04%	157
2017 Q4	$411K	Hold	6,023	–	–	0.03%	173
2017 Q3	$377K	Buy	6,023 +100	+2%	+$5.98K	0.03%	172
2017 Q2	$328K	Sell	5,923 -150	-2%	-$7.81K	0.03%	178
2017 Q1	$305K	Sell	6,073 -50	-0.8%	-$2.44K	0.03%	190
2016 Q4	$303K	Hold	6,123	–	–	0.02%	188
2016 Q3	$321K	Hold	6,123	–	–	0.03%	174
2016 Q2	$273K	Hold	6,123	–	–	0.02%	176
2016 Q1	$251K	Buy	+6,123	New	+$225K	0.02%	171
2014 Q4	–	Sell	-52,189	Closed	-$1.85M	–	167
2014 Q3	$1.85M	Sell	52,189 -2,905	-5%	-$108K	0.11%	82
2014 Q2	$2.15M	Sell	55,094 -3,215	-6%	-$120K	0.13%	77
2014 Q1	$2.12M	Sell	58,309 -1,010,750	-95%	-$36.9M	0.13%	67
2013 Q4	$37M	Sell	1,069,059 -49,626	-4%	-$1.6M	2.35%	7
2013 Q3	$31.2M	Buy	1,118,685 +188,789	+20%	+$5.03M	2.16%	15
2013 Q2	$25.1M	Buy	+929,896	New	+$25.7M	1.88%	28

Other funds holding XYL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Philadelphia Trust Company's XYL Position: Q1 2026 in Review

Philadelphia Trust Company increased its Xylem (XYL) stake by 2.1% in Q1 2026, buying an estimated $9.31K and bringing the position to 3,377 shares worth $404K. The position accounts for 0.03% of the portfolio, ranked #182.

Philadelphia Trust Company first reported a position in XYL in Q2 2013 and has held it in 45 quarters since. The position peaked at $37M in Q4 2013. 1,107 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

Philadelphia Trust Company held 3,377 shares of Xylem worth $404K as of Q1 2026.
Philadelphia Trust Company bought 71 Xylem shares in Q1 2026, an estimated $9.31K.
Xylem made up 0.03% of Philadelphia Trust Company's portfolio in Q1 2026, its #182 holding.
Philadelphia Trust Company first reported a position in Xylem in Q2 2013 and has held it in 45 quarters since.
Philadelphia Trust Company's Xylem position peaked at $37M in Q4 2013.
1,107 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Philadelphia Trust Company's 13F filing for Q1 2026, filed 13 May 2026.